| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/03/2014 | US8741270 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 06/03/2014 | US8741260 Fusion proteins for delivery of GDNF to the CNS |
| 06/03/2014 | CA2799437C Method of producing hydroxyalkyl starch derivatives |
| 06/03/2014 | CA2521410C Inhibitor proteins of a protease and use thereof |
| 06/03/2014 | CA2443995C Endothelial cell expression patterns |
| 06/03/2014 | CA2434490C Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions |
| 06/03/2014 | CA2424890C Ethanol production in gram-positive bacteria with a stabilized mutation in lactate dehydrogenase |
| 06/03/2014 | CA2361334C Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use |
| 06/03/2014 | CA2308119C .alpha.-amylase mutants |
| 05/30/2014 | WO2014082042A2 Peptides that stimulate subcutaneous adipogenesis |
| 05/30/2014 | WO2014081964A1 Novel proteinase inhibitor promotes resistance to insects |
| 05/30/2014 | WO2014081944A2 Egfr and c-met-fibronectin type iii domain binding molecules |
| 05/30/2014 | WO2014081831A1 Methods and compositions for modified factor ix proteins |
| 05/30/2014 | WO2014081772A1 Regeneration of coronary artery by coronary endothelial specific progenitor cells |
| 05/30/2014 | WO2014081702A2 Synthetic linear apelin mimetics for the treatment of heart failure |
| 05/30/2014 | WO2014081673A2 Engineering plants for efficient uptake and utilization of urea to improve crop production |
| 05/30/2014 | WO2014081225A1 Method for preparing novel long-acting human growth hormone monomer |
| 05/30/2014 | WO2014080979A1 Method for detecting neurological disease accompanied by inflammation and/or demyelination |
| 05/30/2014 | WO2014080703A1 Modified galectin-9 protein |
| 05/30/2014 | WO2014080350A1 Immunomodulatory peptides and methods of use thereof |
| 05/30/2014 | WO2014080286A2 Methods and compositions for treating multiple sclerosis and related disorders |
| 05/30/2014 | WO2014080206A1 Methods for the manufacture of proteolytically processed polypeptides |
| 05/30/2014 | WO2014080063A1 Recombinant protein and uses thereof in the diagnosis of multiple sclerosis |
| 05/30/2014 | WO2014079957A1 Selective inhibition of ethylene signal transduction |
| 05/30/2014 | WO2014079898A1 Reconstituted pulmonary surfactants |
| 05/30/2014 | WO2014079878A1 Means and methods for determination of botulinum neurotoxin biological activity |
| 05/30/2014 | WO2014079842A1 Rsv f prefusion trimers |
| 05/30/2014 | WO2014079498A1 Methods for providing cytoplasmic male sterile petroselinum crispum plants, cytoplasmic male sterile petroselinum crispum plants and seeds and plant parts thereof |
| 05/30/2014 | WO2014079495A1 Methods for the manufacture of proteolytically processed polypeptides |
| 05/30/2014 | WO2014079399A1 Polypeptide antagonists of human il-23 receptor for treatment of autoimmune diseases |
| 05/30/2014 | WO2014079384A1 Trophic hormone fusion protein, preparation method and application thereof |
| 05/30/2014 | WO2014078963A1 Anti-lg3 antibody inhibition in the prevention and/or treatment of vascular rejection and related diseases and conditions |
| 05/30/2014 | WO2014078911A1 Compositions for the restoration of a fecal microbiota and methods for making and using them |
| 05/30/2014 | WO2014078900A1 Anti-pathogenic methods |
| 05/30/2014 | WO2014078890A1 Chlamydia trachomatis diagnostic peptide and method |
| 05/30/2014 | WO2014057437A3 Method for preparing c1q recombinant protein |
| 05/30/2014 | WO2014057436A3 Anticancer conjugate |
| 05/30/2014 | WO2014055836A3 Serine protease molecules and therapies |
| 05/30/2014 | WO2014053861A3 Staphylococcus aureus antigens |
| 05/30/2014 | WO2014037519A3 Compositions and methods |
| 05/30/2014 | WO2014037460A3 Immobilised cyclin-dependent kinase 4 fusion proteins and uses thereof |
| 05/30/2014 | WO2014036468A3 Aav mediated aquaporin gene transer to treat sjogren's syndrome |
| 05/30/2014 | WO2014016383A9 Glycoproteins for pseudotyping lentivectors |
| 05/30/2014 | WO2014015116A3 Arterivirus protein and expression mechanisms |
| 05/30/2014 | WO2012149439A3 Il4/il13 binding repeat proteins and uses |
| 05/29/2014 | US20140150138 Novel Proteinase Inhibitor Promotes Resistance to Insects |
| 05/29/2014 | US20140148586 Designing a soluble full-length hiv-1 gp41 trimer |
| 05/29/2014 | US20140148585 Method for purifying protein |
| 05/29/2014 | US20140148582 Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (ma) |
| 05/29/2014 | US20140148580 Process for separating proteins fibrinogen, factor xiii and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins |
| 05/29/2014 | US20140148579 Hydrolysate of a protein substrate and a process for producing thereof |
| 05/29/2014 | US20140148578 Blended soy protein products having altered characteristics |
| 05/29/2014 | US20140148577 Method for immobilizing protein a on a self-assembled monolayer |
| 05/29/2014 | US20140148575 Biodegradable electroconducting nanowire, method of manufacture and uses thereof |
| 05/29/2014 | US20140148397 Appetite stimulating protein |
| 05/29/2014 | US20140148396 Compounds for treating cardiac damage after ischaemia/reperfusion |
| 05/29/2014 | US20140148392 HSA-Related Compositions And Methods Of Use |
| 05/29/2014 | US20140148390 Fusion proteins releasing relaxin and uses thereof |
| 05/29/2014 | US20140148388 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/29/2014 | US20140148378 Antibacterial peptides |
| 05/29/2014 | US20140148355 Compositions and methods for analysis of h3k4 methylated chromatin |
| 05/29/2014 | US20140147462 Compositions and methods for treatment of hematological malignancies |
| 05/29/2014 | US20140147461 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 05/29/2014 | US20140147460 Truncated l1 protein of human papillomavirus type 33 |
| 05/29/2014 | US20140147459 Computationally optimized broadly reactive antigens for h1n1 influenza |
| 05/29/2014 | US20140147458 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same |
| 05/29/2014 | US20140147457 Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof |
| 05/29/2014 | US20140147456 Cetp fragments |
| 05/29/2014 | US20140147453 FUSION PEPTIDE COMPRISING dhFas-1 DOMAIN AND MMP SUBSTRATE AND USE THEREOF FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS |
| 05/29/2014 | US20140147444 Selective binding agents of osteoprotegerin binding protein |
| 05/29/2014 | US20140147441 Compositions containing alpha-1-antitrypsin and methods for use |
| 05/29/2014 | US20140147440 Uses of nanog inhibitors and related methods |
| 05/29/2014 | US20140147435 NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases |
| 05/29/2014 | US20140147426 Anticaries compositions and probiotics/prebiotics |
| 05/29/2014 | US20140147421 C1q/tnf-related protein 12 and compositions and methods of using same |
| 05/29/2014 | US20140147400 Collagen extraction from aquatic animals |
| 05/28/2014 | EP2735616A1 Production method for casein-derived peptides by lactic acid fermentation |
| 05/28/2014 | EP2735611A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 05/28/2014 | EP2735314A1 Improved sugar-coated liposome composition |
| 05/28/2014 | EP2734843A2 Engineered microbe-targeting molecules and uses thereof |
| 05/28/2014 | EP2734632A1 Transcription factors for the production of cellulose degrading enzymes |
| 05/28/2014 | EP2734625A1 Plants having enhanced yield-related traits and a method for making the same |
| 05/28/2014 | EP2734624A1 Down regulating gene expression in insect pests |
| 05/28/2014 | EP2734623A1 Plants resistant to insect pests |
| 05/28/2014 | EP2734622A2 Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage |
| 05/28/2014 | EP2734620A1 Enzymes for degrading organophosphates |
| 05/28/2014 | EP2734614A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 05/28/2014 | EP2734545A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 05/28/2014 | EP2734543A1 Lactoferrin fragments and use thereof |
| 05/28/2014 | EP2734542A2 Pathology biomarker assay |
| 05/28/2014 | EP2734541A2 Novel il-17r-ecd mutants |
| 05/28/2014 | EP2734540A1 Biomarkers for ankylosing spondylitis |
| 05/28/2014 | EP2734539A1 Prame purification |
| 05/28/2014 | EP2734538A2 Method of reversibly staining a target cell |
| 05/28/2014 | EP2734230A1 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
| 05/28/2014 | EP2734221A1 Methods for diagnosing and treating alzheimer's disease by administering an angiogenic agent |
| 05/28/2014 | EP2734219A1 Adenovirus e1a fragments for use in anti-cancer therapies |
| 05/28/2014 | EP2734218A2 Polyoma virus jc peptides and proteins in vaccination and diagnostic applications |
| 05/28/2014 | CN1840178B 肿瘤特异性动物蛋白 Tumor-specific animal protein |
| 05/28/2014 | CN1329667B 在制备多肽的方法中有效的真菌转录激活因子 Be effective in the method of producing a polypeptide of fungal transcriptional activators |